Mostrar el registro sencillo del ítem

dc.contributor.authorLazzari, Tássia Kirchmannpt_BR
dc.contributor.authorSkupien, Erika Cavalheiropt_BR
dc.contributor.authorCoutinho, Sandra Eugeniapt_BR
dc.contributor.authorSilva, Lívia Fontes dapt_BR
dc.contributor.authorSilva, Denise Rossatopt_BR
dc.date.accessioned2021-08-06T04:41:40Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn1932-6203pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/225277pt_BR
dc.description.abstractIntroduction The pathogenesis of consumptive syndrome of tuberculosis (TB) is largely unknown. Leptin concentrations may be high because of the host’s inflammatory response, contributing to weight loss in patients with TB. The receptor for advanced glycation end products (RAGE) is also associated with weight loss in patients with TB and is related to enhanced mortality. The objective of this study was to evaluate the association between leptin and AGE/RAGE. Methods Case-control study. Leptin, AGE (carboxymethyl lysine, CML) and soluble RAGE (sRAGE) were measured from blood samples by ELISA. Results We included in the study 34 patients with TB and 34 controls. We found an inverse correlation between serum leptin levels and sRAGE, only in cases (r = -0.609, p < 0.0001). sRAGE levels were lower in patients with TB who died as compared with patients who survive (21.90 ± 4.24 pg/mL vs 66.14 ± 29.49 pg/mL; p = 0.045). Leptin levels were higher in patients with TB who died as compared with patients who survive (14.11 [7.48–14.11] ng/mL vs 3.08 [0.54–6.34] ng/mL; p = 0.028). Conclusions We identified lower sRAGE levels and higher leptin levels in patients with TB who died as compared with patients who survive. In addition, an inverse and significant correlation between serum leptin and sRAGE levels was demonstrated. Future studies, with a larger sample size and in different settings, including not only hospitalized patients, are needed to confirm these findings.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofPloS one. San Francisco. Vol. 16, no. 7 (July 2021), e0254198, 7 p.pt_BR
dc.rightsOpen Accessen
dc.subjectLeptinapt_BR
dc.subjectTuberculosept_BR
dc.subjectReceptor para produtos finais de glicação avançadapt_BR
dc.titleLeptin and advanced glycation end products receptor (RAGE) in tuberculosis patientspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001129577pt_BR
dc.type.originEstrangeiropt_BR


Ficheros en el ítem

Thumbnail
   

Este ítem está licenciado en la Creative Commons License

Mostrar el registro sencillo del ítem